SHOULD CLINICAL STAGE T2C PROSTATE CANCER BE CLASSIFIED AS INTERMEDIATE- OR HIGH-RISK? - RESULTS FROM THE SEARCH DATABASE

360

  • Singh, Abhay
  • Freedland, Stephen
  • Gerber, Leah
  • Aronson, William
  • Terris, Martha
  • Presti, Joseph
  • Amling, Christopher
  • Kane, Christopher
  • Banez, Lionel L.

  • aDurham, NC

    bLos Angeles, CA

    cAugusta, GA

    dStanford, CA

    ePortland, OR

    fLa Jolla, CA

Source of Funding: Department of Defense, NIH, Duke Division of Urologic Surgery, Georgia Cancer Coalition

Journal of Urology 187(4):p e147, April 2012.
Copyright © 2012 by the American Urological Association, Inc.